As part of the design and marketing of medical devices, guaranteeing the biocompatibility of materials is a fundamental regulatory requirement. While biological tests (cytotoxicity, genotoxicity, etc.) are well known, it is just as crucial to carry out in-depth characterisation of materials, upstream of these tests, in order to control the risks.
This is precisely the purpose of ISO 10993-19, published as part of the ISO 10993 series on the biological evaluation of medical devices.
ISO 10993-19 defines the methods and criteria for analysing the physico-chemical characteristics of materials intended to come into contact with the human body.
It complements the other standards in the ISO 10993 series by proposing a material profile that describes its physical, chemical, morphological and topographical properties. These characteristics directly influence the biological response and must be known before any toxicological assessment.
International regulations (Regulation (EU) 2017/745, FDA 21 CFR, etc.) require scientific justification of biocompatibility. This justification must be provided not only by literature data, but also, and more often than not, by device-specific test results.
Precise knowledge of the nature and structure of the material enables us to anticipate interaction reactions with tissues, body fluids or cells.
The standard classifies characteristics into three main categories:
Physico-chemical characteristics
Morphological characteristics
Topographical characteristics
Depending on the nature of the material and the targeted parameters, different techniques are recommended:
Propriety | Typical analytical method |
Elemental composition | Spectroscopy (ICP-MS, FTIR, XPS) |
Morphology | Optical microscopy, SEM, AFM |
Topography | Profilométrie, Interférométrie |
Crystal structure | X-ray diffraction (XRD) |
Molecular mass | GPC (steric exclusion chromatography) |
Thermal properties | DSC, TGA |
Stage of development | Role of the standard |
Product design | Selection of suitable materials, elimination of risks |
Preparation for CE / FDA | Marking Provision of technical data in the dossier |
Material change | Reassessment of key characteristics |
Supplement to a risk analysis ISO 14971 | Scientific documentation to assess the hazards associated with the material |
ISO 10993-19 is not just a technical exercise: it is a strategic tool for ensuring safety, reducing development costs, and meeting the expectations of regulatory authorities.
By integrating this standard from the earliest stages of a medical device's life cycle, manufacturers have a solid basis for demonstrating the biocompatibility of their products in a scientifically rigorous way that complies with international requirements.
Applus+ uses first-party and third-party cookies for analytical purposes and to show you personalized advertising based on a profile drawn up based on your browsing habits (eg. visited websites). You can accept all cookies by pressing the "Accept" button or configure or reject their use. Consult our Cookies Policy for more information.
They allow the operation of the website, loading media content and its security. See the cookies we store in our Cookies Policy.
They allow us to know how you interact with the website, the number of visits in the different sections and to create statistics to improve our business practices. See the cookies we store in our Cookies Policy.
Based on your behavior on the website (where you click, how long you browse, etc.) we establish parameters and a profile for you to display ads that correspond to your interests. See the cookies we store in our Cookies Policy.